| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cellectis SA (EPA: ALCLS)
Â
ALCLS Technical Analysis
4
| As on 1st Nov 2017 ALCLS Share Price closed @ 26.88 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 21.12 & Buy for SHORT-TERM with Stoploss of 23.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
Â
Â
ALCLS Share Price
| Open | 29.61 | Change | Price | % |
| High | 30.00 | 1 Day | -2.73 | -9.22 |
| Low | 26.72 | 1 Week | 0.00 | 0.00 |
| Close | 26.88 | 1 Month | 1.93 | 7.74 |
| Volume | 325141 | 1 Year | 9.42 | 53.95 |
| 52 Week High 30.00 | 52 Week Low 15.55 | ||||
Â
EPA France Most Active Stocks
| MT | 4.53 | 12.97% |
| MT | 4.53 | 12.97% |
| GSZ | 17.56 | 3.97% |
| BRS | 12.00 | 0.00% |
| VK | 4.72 | 0.43% |
| ALALO | 0.04 | 0.00% |
| CS | 26.31 | 1.47% |
| TEC | 67.40 | 0.40% |
| ACA | 14.98 | 0.00% |
| ALAUP | 0.20 | -13.04% |
Â
EPA France Top Gainers Stocks
Â
EPA France Top Losers Stocks
Â
Â
| ALCLS Daily Charts |
ALCLS Intraday Charts |
Whats New @ Bazaartrend |
ALCLS Free Analysis |
|
|
Â
ALCLS Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 29.92 |
| RESISTANCE | 28.67 |
| SUPPORT | 25.09 |
| SUPPORT | 23.84 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
Â
ALCLS Target for Month August
| 4th UP TARGET | 43.19 |
| 3rd UP TARGET | 38.79 |
| 2nd UP TARGET | 36.07 |
| 1st UP TARGET | 33.35 |
| 1st DOWN TARGET | 25.59 |
| 2nd DOWN TARGET | 22.87 |
| 3rd DOWN TARGET | 20.15 |
| 4th DOWN TARGET | 15.75 |
Â
ALCLS Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
Â
ALCLS Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Â
Cellectis SA ( EPA France Symbol : ALCLS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
Â
ALCLS Business Profile
Cellectis, together with its subsidiaries, operates as a genome engineering company in France and internationally. The company designs and markets meganucleases and TALENs, which are tools that enable targeted modifications to DNA in the research, biomanufacturing, agro biotechnology, and therapeutic sectors; and develops and markets genome customization products used to create stable and isogenic cell lines with various characteristics and performances for use in the drug development, gene function studies, and protein production sectors. It also develops nucleases for various therapeutic applications, including correction of a genetic defect in the patientÂ’s genome; destruction of viral genomes; or inactivation of genes to create cells with modified characteristics in the fields of cancer, viral infections, and genetic diseases. In addition, the company focuses on plant genome modification using nucleases that recognize specific DNA sequences to develop species with traits of value; and development of stem cell technology for controlling stem cell production and differentiation. It has strategic partnership agreement with Les Laboratoires Servier to develop and commercialize product candidates targeting leukemia and solid tumors. Cellectis was founded in 1999 and is based in Paris, France.
Â
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
